Literature DB >> 25566342

The association between cardiovascular risk factors and progressive hippocampus volume loss in persons with Alzheimer's disease.

Iryna Lobanova1, Adnan I Qureshi1.   

Abstract

BACKGROUND: We performed the current study to test the hypothesis that the aggregation of cardiovascular risk factors in patients with Alzheimer's disease (AD) was associated with a higher rate of volume loss in the hippocampus and progression of cognitive deficits.
METHODS: A total of 103 persons with AD were included (65 men and 38 women, average age of 74.5 ± 0.8 years). All participants underwent 1.5 T structural magnetic resonance imaging (MRI), at specified intervals (6 or 12 months) for 2-3 years. We determined the rates of hippocampus, whole brain, ventricle, middle temporal lobe, fusiform, and entorhinal volume loss (in cubic millimeter/year) for all patients with AD, separately for 0-6 months, 6-12 months and 0-12, 12-18 and 18-24 months scan intervals.
RESULTS: There were significant differences in Mini-Mental State Examination (MMSE) (p = 0.001) and Alzheimer's disease Assessment Scale (ADAS) (p = 0.01) scale scores between persons with and without hypertension and in MMSE (p = 0.04) and Clinical Dementia Rating (CDR) (p = 0.008) scale scores between persons with and without hyperlipidemia. There were no significant differences in MMSE, ADAS, and CDR scales scores between persons with and without diabetes mellitus and cigarette smoking. There were no significant differences in regional brain volume loss in those with or without cardiovascular risk factors.
CONCLUSIONS: Cardiovascular risk factors have a significant influence on the progression of cognitive deficits in patients with AD. The progression of cognitive deficits in patients with AD is not mediated by progressive hippocampal volume loss.

Entities:  

Keywords:  Alzheimer’s disease; cardiovascular risk factors; hippocampus volume loss; magnetic resonance imaging

Year:  2014        PMID: 25566342      PMCID: PMC4280866     

Source DB:  PubMed          Journal:  J Vasc Interv Neurol        ISSN: 1941-5893


  20 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study.

Authors:  N C Fox; E K Warrington; P A Freeborough; P Hartikainen; A M Kennedy; J M Stevens; M N Rossor
Journal:  Brain       Date:  1996-12       Impact factor: 13.501

3.  3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI.

Authors:  Liana G Apostolova; Paul M Thompson; Amity E Green; Kristy S Hwang; Charleen Zoumalan; Clifford R Jack; Danielle J Harvey; Ronald C Petersen; Leon J Thal; Paul S Aisen; Arthur W Toga; Jeffrey L Cummings; Charles S Decarli
Journal:  Hum Brain Mapp       Date:  2010-05       Impact factor: 5.038

4.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

5.  Visualisation and quantification of rates of atrophy in Alzheimer's disease.

Authors:  N C Fox; P A Freeborough; M N Rossor
Journal:  Lancet       Date:  1996-07-13       Impact factor: 79.321

6.  CARDIOVASCULAR RISK FACTORS AFFECT HIPPOCAMPAL MICROVASCULATURE IN EARLY AD.

Authors:  Elizabeth Schwartz; Bridget Wicinski; James Schmeidler; Vahram Haroutunian; Patrick R Hof
Journal:  Transl Neurosci       Date:  2010-01-01       Impact factor: 1.757

Review 7.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

8.  The neuropathology of probable Alzheimer disease and mild cognitive impairment.

Authors:  Julie A Schneider; Zoe Arvanitakis; Sue E Leurgans; David A Bennett
Journal:  Ann Neurol       Date:  2009-08       Impact factor: 10.422

9.  MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers.

Authors:  N Schuff; N Woerner; L Boreta; T Kornfield; L M Shaw; J Q Trojanowski; P M Thompson; C R Jack; M W Weiner
Journal:  Brain       Date:  2009-02-27       Impact factor: 13.501

10.  Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI.

Authors:  Rachael I Scahill; Jonathan M Schott; John M Stevens; Martin N Rossor; Nick C Fox
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

View more
  3 in total

1.  Relationship between the gene polymorphisms of kallikrein-kinin system and Alzheimer's disease in a Hunan Han Chinese population.

Authors:  Yanyao Deng; Deren Hou; Mi Tian; Wei Li; Xialu Feng; Zhuling Yu
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01

Review 2.  Interaction between therapeutic interventions for Alzheimer's disease and physiological Aβ clearance mechanisms.

Authors:  Christopher D Morrone; Mingzhe Liu; Sandra E Black; JoAnne McLaurin
Journal:  Front Aging Neurosci       Date:  2015-05-05       Impact factor: 5.750

3.  Association between white matter lesions and cerebral Aβ burden.

Authors:  Hyon-Ah Yi; Kyoung Sook Won; Hyuk Won Chang; Hae Won Kim
Journal:  PLoS One       Date:  2018-09-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.